Arbutus Biopharma Corp (NASDAQ:ABUS)
| 2.47 BATS BZX Real-Time Price As of 12:58pm ET |  +0.055 / +2.28%Today’s Change | 2.39 Today|||52-Week Range 6.50 | -36.63% Year-to-Date |
Latest ABUS News | Press Releases
No recent news for Arbutus Biopharma Corp.
Today’s Trading
| Previous close | 2.41 |
| Today’s open | 2.42 |
| Day’s range | 2.39 - 2.50 |
| Volume | 72,277 |
| Average volume (3 months) | 7,729,105 |
| Market cap | $363.2M |
Data as of 12:58pm ET, 01/28/2022
Growth & Valuation
| Earnings growth (last year) | +65.36% |
| Earnings growth (this year) | +13.60% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +15.02% |
| P/E ratio | NM |
| Price/Sales | 38.94 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AERIAerie Pharmaceutical... | +0.06 | +0.87% |
| GRTSGritstone bio Inc | +0.05 | +1.06% |
| AVDLAvadel Pharmaceutica... | +0.09 | +1.65% |
| AKBAAkebia Therapeutics ... | +0.03 | +1.92% |
Data as of 12:59pm ET, 01/28/2022
Financials
| Next reporting date | March 10, 2022 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $6.9M |
| Annual profit (last year) | -$63.7M |
| Net profit margin | -921.97% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Warminster, Pennsylvania |
Forecasts
